SILVER SPRING, Md., Dec. 19, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. Cases of EVD...
from PR Newswire: https://ift.tt/2PCmnwq
No comments:
Post a Comment